Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Follow-Up Questions
Champions Oncology Inc (CSBR) 的本益比是多少?
Champions Oncology Inc 的本益比是 19.8276
Champions Oncology Inc 的 CEO 是誰?
Dr. Ronnie Morris 是 Champions Oncology Inc 的 Chief Executive Officer,自 2010 加入公司。
CSBR 股票的價格表現如何?
CSBR 的當前價格為 6.6,在上個交易日 decreased 了 1.41%。
Champions Oncology Inc 的主要業務主題或行業是什麼?
Champions Oncology Inc 屬於 Life Sciences Tools & Services 行業,該板塊是 Health Care